Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced it will showcase data across its portfolio of high-quality comprehensive genomic profiling tests at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29-June 2 in Chicago. Data from 14 abstracts will be presented on copy number loss detection, serial circulating tumor DNA (ctDNA) genomic profiling, Foundation Medicine’s proprietary homologous recombination deficiency signature (HRDsig) and more.
To access the abstracts being presented at the 2026 ASCO Annual Meeting, please visit ASCO.org/abstracts.
Follow Foundation Medicine on LinkedIn, X and Instagram for more updates from #ASCO26 and visit us in person at booth #19145.
Foundation Medicine’s Abstracts at the 2026 ASCO Annual Meeting
